Level Biotechnology Inc.

NT$30.30As of Sun 8 Nov 2026, 12:00 UTC
TPEx:3118Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR 5.47%
Div yield 7.26%
ROE 11.55%
Biotechnology
Beta (5Y) 0.23
PE TTM 15.30
TSR TTM (3.95%)
Mkt cap NT$983.3M
ROIC 15.49%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$39
29.03%
(32.87%)
Hold 0|10|3|10|5
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.38
0.39
0.42
0.44
15.45%
16.01%
17.22%
23.15%
RevenueNT$M
72.57
76.90
79.13
79.44
1.48%
7.77%
12.76%
9.68%
Peers (US$29.70M)
Cap (US$)
PE
30.17M
—
Capital
TTM
5Y
10Y
Leveragex
0.922
0.077
0.061
EBIT/Intx
0.172
0.132
0.129
Own earn%
(466.10)
216.18
181.01
Sh yield%
32.68
39.88
33.57
Owners
Insiders/Inst%
10.03
21.21
Short interest%
2.23
SBC / revenue%
2.15
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
13–21
$1 testx
0.1
Incr. ROIC%
0